FDA Buys Nine Waters Acquity UPLC Systems | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has bought nine of Waters' Acquity UltraPerformance Liquid Chromatography systems for use in its food and consumer safety monitoring research programs, the company said today.

FDA bought the nine Acquity systems for its Center for Food Safety and Applied Nutrition's Office of Regulatory Science, based in College Park, Md., which currently has three Acquity UPLC systems and two nanoAcquity UPLC Systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.